David Nanchen
Overview
Explore the profile of David Nanchen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
120
Citations
1618
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Boudon A, Locatelli I, Gencer B, Carballo D, Klingenberg R, Raber L, et al.
BMJ Open
. 2025 Jan;
15(1):e088262.
PMID: 39819911
Objectives: To assess the association between the intensity of statin therapy and the level of physical activity in patients 1 year after an acute coronary syndrome (ACS). Design: Prospective cohort...
2.
Sievering I, Senouf O, Mahendiran T, Nanchen D, Fournier S, Muller O, et al.
IEEE Open J Eng Med Biol
. 2024 Nov;
5:837-845.
PMID: 39559783
In patients with coronary artery disease, the prediction of future cardiac events such as myocardial infarction (MI) remains a major challenge. In this work, we propose a novel anatomy-informed multimodal...
3.
Johner N, Branca M, Carballo D, Baggio S, Nanchen D, Tessitore E, et al.
Eur J Prev Cardiol
. 2024 Oct;
PMID: 39454630
Aims: The benefit of long-term beta-blocker therapy after acute coronary syndromes (ACS) without heart failure in the reperfusion era is uncertain. Two recent randomized trials found conflicting results. The present...
4.
Follonier C, Rabassa G, Branca M, Carballo D, Koskinas K, Heg D, et al.
Atheroscler Plus
. 2024 Oct;
58:1-8.
PMID: 39351317
Background And Aims: The 2019 European Society of Cardiology guidelines for the management of dyslipidemia consider the use of high-dose marine omega-3 fatty acid (FA) eicosapentaenoic acid (EPA) supplementation (icosapent...
5.
Krasieva K, Gencer B, Locatelli I, Carballo D, Muller O, Fournier S, et al.
Circ Cardiovasc Qual Outcomes
. 2024 Jun;
17(8):e010790.
PMID: 38899458
Background: Long-term control of cardiovascular risk factors after acute coronary syndrome (ACS) is the cornerstone for preventing recurrence. We investigated the extent of cardiovascular risk factor management in males and...
6.
Ray K, Aguiar C, Arca M, Connolly D, Eriksson M, Ferrieres J, et al.
Eur J Prev Cardiol
. 2024 Jun;
31(15):1792-1803.
PMID: 38861400
Aims: To assess whether implementation of the 2019 European Society of Cardiology (ESC)/European Atherosclerosis Society (EAS) dyslipidaemia guidelines observed between 2020 and 2021 improved between 2021 and 2022 in the...
7.
Krasieva K, Tzimas G, Nanchen D
Rev Med Suisse
. 2024 Mar;
20(864):500-504.
PMID: 38445680
The coronary artery calcium score (CAC-score) using imaging is a cardiovascular screening tool that can be used in adults with no known cardiovascular disease and no symptoms suggestive of a...
8.
Emery O, Nanchen D, Chamberlain J
Rev Med Suisse
. 2024 Mar;
20(864):496-499.
PMID: 38445679
As the risk of developing cardiovascular disease (CVD) is strongly dependent on the environment, the study of associated epigenetic modifications is a potentially promising axe of research given that they...
9.
Thiebaud L, Nanchen D, Bize R, Baggish A, Saubade M
Rev Med Suisse
. 2024 Mar;
20(864):488-495.
PMID: 38445678
A sedentary lifestyle is a significant cardiovascular risk factor and increases premature mortality. Engaging in routine physical activity (PA) provides a wide range of health benefits. Accordingly, physical inactivity must...
10.
Tarteret P, Campbell D, Vassaux S, Prior J, Darioli R, Nanchen D
Rev Med Suisse
. 2024 Mar;
20(864):466-471.
PMID: 38445675
Mobile cardiovascular prevention interventions are still uncommon in Switzerland. Mobile clinics improve access to prevention and enable new diagnoses of hypertension or hypercholesterolemia to be identified in a cost-effective way...